Sponsor

Seoul National University Bundang Hospital

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Seoul National University Bundang Hospital appears in 130 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials130
Recruiting shown14
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 DiabetesNCT07719894 · lead sponsor · 2026-05-06
RECRUITING
Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis StemNCT07828080 · lead sponsor · 2025-06-18
RECRUITING
SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary ResectionNCT07102589 · lead sponsor · 2025-06-01
RECRUITING
Cilostazol-Ginkgo for Cognitive Function in Elderly DiabetesNCT06989697 · lead sponsor · 2025-01-01
RECRUITING
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesNCT06989723 · lead sponsor · 2025-01-01
RECRUITING
Clopidogrel Versus Cilostazol on VesselsNCT06402747 · lead sponsor · 2024-04-16
RECRUITING
Enavogliflozin vs. Pioglitazone on Glucose and AtherosclerosisNCT06399835 · lead sponsor · 2024-02-01
RECRUITING
The EMPA-FIT StudyNCT06846411 · lead sponsor · 2024-01-01
RECRUITING
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaNCT05365425 · lead sponsor · 2023-06-01
RECRUITING
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung LesionsNCT05804786 · lead sponsor · 2023-04-01
RECRUITING
Dual-chamber Patient-controlled Analgesia for Postoperative RecoveryNCT07051109 · lead sponsor · 2022-10-11
RECRUITING
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaNCT05365438 · lead sponsor · 2022-10-01
RECRUITING
Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled TrialNCT05211375 · lead sponsor · 2022-01-03
RECRUITING
Korean Heart Failure Registry IIINCT04329234 · lead sponsor · 2018-10-01
RECRUITING
Effectiveness of Video-Based Movement Analysis-Guided Personalized Rehabilitation in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)NCT07714278 · lead sponsor · 2026-06-30
ENROLLING_BY_INVITATION
Effect of Positive End-expiratory Pressure on the Gastric VolumeNCT06861569 · lead sponsor · 2025-03-15
UNKNOWN
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DNCT05140694 · lead sponsor · 2023-12-01
UNKNOWN
Remimazolam vs Propofol as an Induction Agent for Morbid Obesity PatientsNCT05856617 · lead sponsor · 2022-10-25
UNKNOWN
Mobile App for Heart FailureNCT05668000 · lead sponsor · 2022-10-19
COMPLETED
Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy PatientsNCT05253170 · lead sponsor · 2022-04-01
NOT_YET_RECRUITING
Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and SafetyNCT05915949 · lead sponsor · 2022-01-01
UNKNOWN
Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation BronchoscopyNCT05110131 · lead sponsor · 2021-12-01
UNKNOWN
Carvedilol in HF With Preserved EFNCT05553314 · lead sponsor · 2021-11-17
COMPLETED
Vagus Nerve Preservation and Chronic Cough in Non-small Cell Lung Cancer SurgeryNCT04923412 · lead sponsor · 2021-07-01
UNKNOWN
Needle Radiofrequency Treatment for Submental FatNCT05517824 · lead sponsor · 2021-06-07
COMPLETED
ERAS After Bariatric Surgery in Morbidly ObeseNCT04891822 · lead sponsor · 2021-06-02
COMPLETED
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and HypertensionNCT05189015 · lead sponsor · 2021-01-01
COMPLETED
The Development of Quantitative Ultrasound Imaging Software PlatformNCT05836246 · lead sponsor · 2020-09-01
UNKNOWN
Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 DiabetesNCT05663736 · lead sponsor · 2020-01-01
UNKNOWN
Mobile App for BP ControlNCT04470284 · lead sponsor · 2019-09-01
COMPLETED
Effect of Empagliflozin on Body Composition and KetonesNCT03877406 · lead sponsor · 2018-08-01
UNKNOWN
Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and HypertensionNCT05173025 · lead sponsor · 2018-01-01
UNKNOWN
Effects on the Personalized Rehabilitation Service in Patients With CancerNCT03200067 · lead sponsor · 2017-06-03
UNKNOWN
Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and MetforminNCT03076112 · lead sponsor · 2017-04-25
COMPLETED
Effect of Aging & Obesity With Exercise InterventionNCT03951857 · lead sponsor · 2016-11-18
COMPLETED
Immediate Release Versus Slow Release Carvedilol in Heart FailureNCT03209180 · lead sponsor · 2016-10-27
UNKNOWN
Effectiveness of Nefopam in Breast Cancer SurgeryNCT02949310 · lead sponsor · 2016-10-01
UNKNOWN
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 DiabetesNCT03248401 · lead sponsor · 2016-09-26
COMPLETED
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic SignificanceNCT03024476 · lead sponsor · 2016-09-01
COMPLETED
Korean OBEsity Surgical Treatment StudyNCT03100292 · lead sponsor · 2016-09-01
UNKNOWN
Investigation of Anti-obesity Properties of Lactobacillus Sakei in Obese Human SubjectsNCT03248414 · lead sponsor · 2016-08-10
COMPLETED
Therapeutic Efficacy of Categorical Language Fluency Smartphone Game ApplicationNCT02848404 · lead sponsor · 2016-06-01
COMPLETED
The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With DiabetesNCT03249259 · lead sponsor · 2016-03-10
COMPLETED
Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure ManagementNCT02673073 · lead sponsor · 2016-01-01
UNKNOWN
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in HypertensionNCT03226340 · lead sponsor · 2015-12-02
UNKNOWN
Development of Personalized Health Care Service in Patients With Breast CancerNCT03194399 · lead sponsor · 2015-11-27
COMPLETED
Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideNCT02610088 · lead sponsor · 2015-11-01
COMPLETED
Initial Combination of Gemigliptin and Metformin on Microbiota ChangeNCT02609815 · lead sponsor · 2015-11-01
COMPLETED
Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer PatientsNCT03067012 · lead sponsor · 2015-09-01
COMPLETED
A Prospective Cohort Study of Aged People for Chronic DiseasesNCT02640872 · lead sponsor · 2015-07-01
COMPLETED
The Preemptive Analgesic Efficacy of NefopamNCT02561468 · lead sponsor · 2015-04-01
COMPLETED
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyNCT02338921 · lead sponsor · 2015-01-01
COMPLETED
Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 DiabetesNCT02185963 · lead sponsor · 2014-10-01
COMPLETED
Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes ManagementNCT02315287 · lead sponsor · 2014-09-01
UNKNOWN
Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic PatientsNCT02188186 · lead sponsor · 2014-07-01
COMPLETED
Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood PressureNCT03255551 · lead sponsor · 2014-01-01
COMPLETED
Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes CareNCT02025296 · lead sponsor · 2013-12-01
COMPLETED
Efficacy and Safety of Voice Inception Technique Based U-healthcare Service in Patients With Type 2 Diabetes MellitusNCT01891474 · lead sponsor · 2013-08-01
COMPLETED
Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderNCT01997580 · lead sponsor · 2013-07-01
UNKNOWN
The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular RiskNCT01972542 · lead sponsor · 2013-06-01
COMPLETED

Drugs studied in this sponsor's trials

43 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Seoul National University Bundang Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo7
aspirin4
cilostazol4
sitagliptin3
clopidogrel2
dapagliflozin2
empagliflozin 10 MG2
metformin2
placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 7 trials aspirin RxCUI 1191 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 4 trials cilostazol RxCUI 21107 · Lead sponsor in 4 linked trial(s) · 2 currently recruiting 4 trials sitagliptin RxCUI 593411 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials clopidogrel RxCUI 32968 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials dapagliflozin RxCUI 1488564 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials empagliflozin 10 MG RxCUI 1545654 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials metformin RxCUI 6809 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials nefopam RxCUI 7285 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials pioglitazone RxCUI 33738 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials abciximab RxCUI 83929 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial amantadine sulfate RxCUI 621 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial atorvastatin / ezetimibe RxCUI 1422085 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial brigatinib RxCUI 1921217 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial carvedilol RxCUI 20352 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial choline fenofibrate RxCUI 1433887 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial clozapine RxCUI 2626 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin 10 MG Oral Tablet RxCUI 1488569 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial donepezil RxCUI 135447 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dulaglutide RxCUI 1551291 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial empagliflozin RxCUI 1545653 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial empagliflozin 10 MG [Jardiance] RxCUI 1545660 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial escitalopram RxCUI 321988 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial gliclazide RxCUI 4816 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor84
collaborator46
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.